financetom
Business
financetom
/
Business
/
BMO Raises Altus Target to $59 After Property Tax Sale
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BMO Raises Altus Target to $59 After Property Tax Sale
Jul 10, 2024 12:05 PM

02:24 PM EDT, 07/10/2024 (MT Newswires) -- Altus Group ( ASGTF ) announced the sale of its property tax business to Ryan, LLC for $700 million, notes BMO. While unexpected, the divestiture should allow Altus to refocus efforts on its higher-growth, higher-margin Analytics business and provide flexibility to pay down debt and return cash to shareholders, analyst Stephen MacLeod writes.

Altus also reiterated 2024E guidance.

BMO is lowering its 2025E estimates to reflect the sale of the property tax business in H1/25E.

Target increased to $59. Maintain Market Perform.

Price: 55.44, Change: -0.02, Percent Change: -0.04

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Tanzanian LNG project delayed as government seeks to change terms, sources say
Tanzanian LNG project delayed as government seeks to change terms, sources say
May 6, 2024
LONDON, May 6 (Reuters) - Negotiations for the development of Tanzania's $42 billion liquefied natural gas export plant have been delayed by proposed government changes to a financial agreement reached last year, two sources from companies involved in the project said. The government and investors announced last May they had completed negotiations on the long-delayed project to unlock Tanzania's vast...
KKR to buy India's Healthium Medtech at $839 million valuation, sources say
KKR to buy India's Healthium Medtech at $839 million valuation, sources say
May 6, 2024
MUMBAI/BENGALURU (Reuters) -Global investment firm KKR will buy Indian medical devices maker Healthium Medtech from UK-based Apax Partners in a deal that three sources with direct knowledge of the matter say is valued at 70 billion rupees ($838.60 million). Healthium and Apax did not immediately respond to Reuters' requests seeking comment, while KKR declined to comment. KKR will acquire Healthium...
Hims & Hers Health Insider Sold Shares Worth $4,200,307, According to a Recent SEC Filing
Hims & Hers Health Insider Sold Shares Worth $4,200,307, According to a Recent SEC Filing
May 6, 2024
03:23 AM EDT, 05/06/2024 (MT Newswires) -- Andrew Dudum, 10% Owner, Director, Chief Executive Officer, on May 01, 2024, sold 333,332 shares in Hims & Hers Health ( HIMS ) for $4,200,307. Following the Form 4 filing with the SEC, Dudum has control over a total of 11,241,475 shares of the company, with 11,241,475 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1773751/000177375124000125/xslF345X03/wk-form4_1714775923.xml Price:...
Day One Biopharmaceuticals Insider Sold Shares Worth $1,081,191, According to a Recent SEC Filing
Day One Biopharmaceuticals Insider Sold Shares Worth $1,081,191, According to a Recent SEC Filing
May 6, 2024
03:22 AM EDT, 05/06/2024 (MT Newswires) -- Charles N York II, Chief Operating and Financial Officer, Secretary, on May 01, 2024, sold 60,461 shares in Day One Biopharmaceuticals ( DAWN ) for $1,081,191. Following the Form 4 filing with the SEC, York has control over a total of 217,293 shares of the company, with 217,293 shares held directly. SEC Filing:...
Copyright 2023-2026 - www.financetom.com All Rights Reserved